济川药业(600566.SH)前三季度净利润10.22亿元，同比下降46.27%

Group 1 - The core viewpoint of the article is that Jichuan Pharmaceutical (600566.SH) reported a significant decline in both revenue and net profit for the first three quarters of 2025 compared to the previous year [1] Group 2 - The total operating revenue for the first three quarters reached 3.932 billion yuan, representing a year-on-year decrease of 32.27% [1] - The net profit attributable to shareholders of the parent company was 1.022 billion yuan, reflecting a year-on-year decline of 46.27% [1] - The basic earnings per share stood at 1.11 yuan [1]